IPG Photonics Corporation shares jumped 14.4% after reporting second-quarter 2026 results that beat profit expectations and announcing a binding offer to acquire Lumibird Medical. Sales rose to US$278.58 million from US$250.72 million a year earlier, while net income eased to US$5.24 million from US$6.61 million and basic earnings per share from continuing operations moved to US$0.12 from US$0.16. The company highlighted ongoing 11% year-over-year revenue growth driven by industrial and emerging laser applications. The Lumibird Medical acquisition aims to broaden its medical laser platform and increase its potential medical market by about US$1 billion.
Microsoft Corporation
NVIDIA Corporation
IPG Photonics CorporationQ2 beat and acquisition plan drive shares up 14.4%
Lumibird SAAcquisition by IPG broadens medical laser platform and market
